Literature DB >> 2403715

Shifting patterns of cortical cholinesterases in Alzheimer's disease: implications for treatment, diagnosis, and pathogenesis.

M M Mesulam1, C Geula.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2403715

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  4 in total

1.  Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease.

Authors:  C I Wright; C Guela; M M Mesulam
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

2.  Brain acetylcholinesterase promotes amyloid-beta-peptide aggregation but does not hydrolyze amyloid precursor protein peptides.

Authors:  E O Campos; A Alvarez; N C Inestrosa
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

Review 3.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

4.  Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-Amyloid.

Authors:  María-Salud García-Ayllón; David H Small; Jesús Avila; Javier Sáez-Valero
Journal:  Front Mol Neurosci       Date:  2011-09-13       Impact factor: 5.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.